CAPTRUST Financial Advisors’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $643K | Buy |
|
|||||
|
2025
Q1 | $581K | Buy |
|
|||||
|
2024
Q4 | $629K | Buy |
|
|||||
|
2024
Q3 | $294K | Sell |
|
|||||
|
2024
Q2 | $274K | Sell |
|
|||||
|
2024
Q1 | $352K | Buy |
|
|||||
|
2023
Q4 | $256K | Sell |
|
|||||
|
2023
Q3 | $286K | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $226K | Buy |
|
|||||
|
2022
Q4 | $215K | Buy |
|
|||||
|
2022
Q3 | $200K | Buy |
|
|||||
|
2022
Q2 | $93K | Buy |
|
|||||
|
2022
Q1 | $96K | Buy |
|
|||||
|
2021
Q4 | $33K | Buy |
|
|||||
|
2021
Q3 | $28K | Buy |
|
|||||
|
2021
Q2 | $28K | Sell |
|
|||||
|
2021
Q1 | $24K | Buy |
|
|||||
|
2020
Q4 | $7K | Buy |
|
|||||
|
2020
Q3 | $5K | Buy |
|
|||||
|
2020
Q2 | $4K | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $4K | Hold |
|
|||||
|
2019
Q2 | $4K | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $1K | Buy |
|